ARTICLE SOURCE: Kyle Davidson – Vice President & Manager – Life Sciences Division Evans General Contractors

Today’s Pharmaceutical & Biotechnology market requires Life Science companies to be dynamic and forward thinking in all aspects of their business. This includes the efficient use of capital to support product launch or capacity increases. Many C‐Suite conference room discussions on CAPEX requests routinely focus on capacity utilization, capacity v. market demand, cost probability models, and risks affecting outcomes. The successful project outcome, which is defined in the CAPEX request, includes financial metrics such as Total Project Cost (TPC), Return on Investment (ROI), Net Present Value (NPV) and schedule metrics such as Project Start, Construction Completion, and Ready to Launch.